Pharmaceutical Research Acute Heart Failure Therapeutics Market 2026 | Page 2

REPORT DESCRIPTION
Acute Heart Failure (AHF) Therapeutics Market Overview
Acute heart failure (AHF) is a progressive condition, in which, the heart muscle is unable to
pump enough blood through the heart to meet body’ optimal blood and oxygen level.
Congestive heart failure is type of heart failure which requires timely medical attention.
Moreover, distinguish between acute and chronic heart failure is important from a clinical
standpoint, on which further medication depends. For this, N terminal proB-type natriuretic
peptide levels are used for distinguishing acute versus chronic left ventricular dysfunction.
An elevated levels of natriuretic peptide were present in patients with acute heart failure
compared to those with chronic heart failure patient.
Download PDF Brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/1910
Heart failure symptoms vary widely from person to person, depending on types of heart
failure patient. The main symptoms of heart failure are caused due to fluid accumulation or
congestion and poor blood flow to the body. Symptoms caused by fluid accumulation or
congestion includes shortness of breath, weight gain, coughing, swollen ankles, legs or
abdomen, while dizziness, rapid heart rate, and fatigue are symptoms associated with
reduced blood flow to parts of the body.
© Coherent market Insights. All Rights Reserved